Morphine for chronic neuropathic pain in adults

Area of Science:

• Neurology
• Pain Management
• Pharmacology

Background:

• Neuropathic pain arises from somatosensory system damage, presenting as burning, shooting sensations, or heightened sensitivity to stimuli.
• It is a common symptom in various neurological disorders.
• Morphine, an opioid analgesic, is frequently prescribed for neuropathic pain, though reviews often group it with other opioids.

Purpose of the Study:

• To evaluate the analgesic effectiveness of morphine for chronic neuropathic pain in adults.
• To assess the incidence and nature of adverse events associated with morphine use in this patient population.

Main Methods:

• A systematic review of randomized, double-blind trials of at least two weeks' duration was conducted.
• Searches included CENTRAL, MEDLINE, and Embase databases, along with reference lists and clinical trial registries.
• Included studies compared morphine (any administration route) against placebo or active treatments for neuropathic pain, utilizing participant-reported pain assessments.

Main Results:

• Five studies involving 236 participants with various neuropathic pain types were analyzed.
• Exploratory analysis suggested moderate pain improvement in 63% of participants on morphine versus 36% on placebo (NNT 3.7), but evidence quality was very low.
• No significant difference was found for substantial pain relief.
• Withdrawal rates were slightly higher with morphine, and adverse events were typical of opioids, though inconsistently reported.

Conclusions:

• There is insufficient evidence to definitively support or refute the efficacy of morphine for treating neuropathic pain.
• The quality of evidence for both efficacy and harm was assessed as very low due to small study sizes and limited events.